Transmenopausal changes in trabecular bone quality

Journal of Bone and Mineral Research

Volumn 29, Issue 3, 2014, Pages 608-617

  Gamsjaeger, Sonja ^a   Brozek, Wolfgang ^a   Recker, Robert ^b   Klaushofer, Klaus ^a   Paschalis, Eleftherios P ^a  

^a HANUSCH HOSPITAL   (Austria)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bone quality; menopause; Raman microspectroscopic analysis

Indexed keywords

BONE QUALITY; MENOPAUSE; RAMAN MICROSPECTROSCOPIC ANALYSIS;

BONE AND BONES; FEMALE; FLUORESCENT DYES; HUMANS; MENOPAUSE; MIDDLE AGED; SPECTRUM ANALYSIS, RAMAN;

EID: 84894458073     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2073     Document Type: Article

References (71)

1. Ettinger B, Pressman A, Sklarin P, Bauer DC, Cauley JA, Cummings SR., Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures. J Clin Endocrinol Metab. 1998; 83 (7): 2239-43.
2. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC., Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet. 1976; 1 (7968): 1038-41.
3. Polly BJ, Yuya PA, Akhter MP, Recker RR, Turner JA., Intrinsic material properties of trabecular bone by nanoindentation testing of biopsies taken from healthy women before and after menopause. Calcif Tissue Int. 2012; 90 (4): 286-93.
4. Recker RR, Saville PD, Heaney RP., Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med. 1977; 87 (6): 649-55.
5. Akhter MP, Lappe JM, Davies KM, Recker RR., Transmenopausal changes in the trabecular bone structure. Bone. 2007; 41 (1): 111-6.
6. Recker R, Lappe J, Davies KM, Heaney R., Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. J Bone Miner Res. 2004; 19 (10): 1628-33.
7. Boyce TM, Bloebaum RD., Cortical aging differences and fracture implications for the human femoral neck. Bone. 1993; 14 (5): 769-78.
8. Marshall D, Johnell O, Wedel H., Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996; 312 (7041): 1254-9.
9. Cummings SR., Are patients with hip fractures more osteoporotic? Review of the evidence. Am J Med. 1985; 78 (3): 487-94.
10. McCreade RB, Goldstein AS., Biomechanics of fracture: is bone mineral density sufficient to assess risk ? J Bone Miner Res. 2000; 15 (12): 2305-8.
11. Manolagas SC., Corticosteroids and fractures: a close encounter of the third cell kind [editorial; comment]. J Bone Miner Res. 2000; 15 (6): 1001-5.
12. Hui S, Slemenda CW, Johnston CC., Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988; 81: 1804-9.
13. Jepsen KJ, Schaffler MB., Bone mass does not adequately predict variations in bone fragility: a genetic approach. Trans Orthop Res Soc. 2011; 26: 114.
14. Parfitt AM., Bone remodeling and bone loss: understanding the pathophysiology of osteoporosis. Clin Obs Gynecol. 1987; 30: 789-811.
15. Mosekilde L, Mosekilde L, Danielsen CC., Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals. Bone. 1987; 8: 79-85.
16. McCabe F, Zhou LJ, Steele CR, Marcus R., Noninvasive assessment of ulnar bending stiffness in women. J Bone Miner Res. 1991; 6: 53-9.
17. Kanis JA, Melton LJI, Christiansen C, Johnston CJ, Haltaev N., Perspective: the diagnosis of osteoporosis. J Bone Miner Res. 1994; 9: 1137-42.
18. Kann P, Graeben S, Beyer J., Age-dependence of bone material quality shown by the measurement of frequency of resonance in the ulna. Calcif Tissue Int. 1994; 54: 96-100.
19. Schnitzler CM., Bone quality: a determinant for certain risk factors for bone fragility. Calcif Tissue Int. 1993; 53: S27-31.
20. Ott SM., When bone mass fails to predict bone failure. Calcif Tissue Int. 1993; 53 (Suppl): S7-S13.
21. Cummings SR, Black DM, Nevitt MC, et al. Appendicular bone density and age predict hip fracture in women: the study of osteoporotic fractures research group. JAMA. 1990; 263: 665-8.
22. Fratzl P, Gupta H, Paschalis E, Roschger P., Structure and mechanical quality of the collagen-mineral nano-composite in bone. J Mater Chem. 2004; 14: 2115-23.
23. Einhorn TA., The bone organ system: form and function. In:, Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. New York: Academic Press Inc; 1996.
24. Gamsjaeger S, Buchinger B, Zwettler E, et al. Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly zoledronic acid. J Bone Miner Res. 2010; 26 (1): 12-8.
25. Bansil R, Yannas IV, Stanley HE., Raman spectroscopy: a structural probe of glycosaminoglycans. Biochim Biophys Acta. 1978; 541 (4): 535-42.
26. Ellis R, Green E, Winlove C., Structural analysis of glycosaminoglycans and proteoglycans by means of Raman microspectrometry. Connect Tissue Res. 2009; 50: 29-36.
27. Penel G, Delfosse C, Descamps M, Leroy G., Composition of bone and apatitic biomaterials as revealed by intravital Raman microspectroscopy. Bone. 2005; 36 (5): 893-01.
28. Kazanci M, Fratzl P, Klaushofer K, Paschalis EP., Complementary information on in vitro conversion of amorphous (precursor) calcium phosphate to hydroxyapatite from Raman microspectroscopy and wide-angle X-ray scattering. Calcif Tissue Int. 2006; 79 (5): 354-9.
29. Morris MD, Mandair GS., Raman Assessment of bone quality. Clin Orthop Relat Res. 2011; 469 (8): 2160-9.
30. Carden A, Morris MD., Application of vibrational spectroscopy to the study of mineralized tissues (review). J Biomed Opt. 2000; 5 (3): 259-68.
31. Carden A, Rajachar RM, Morris MD, Kohn DH., Ultrastructural changes accompanying the mechanical deformation of bone tissue: a Raman imaging study. Calcif Tissue Int. 2003; 72 (2): 166-75.
32. Paschalis EP, Tatakis DN, Robins S, et al. Lathyrism-induced alterations in collagen cross-links influence the mechanical properties of bone material without affecting the mineral. Bone. 2011; 49: 1232-41.
33. Paschalis EP, Verdelis K, Doty SB, Boskey AL, Mendelsohn R, Yamauchi M., Spectroscopic characterization of collagen cross-links in bone. J Bone Miner Res. 2001; 16 (10): 1821-8.
34. Donnelly E, Chen DX, Boskey AL, Baker SP, van der Meulen MC., Contribution of mineral to bone structural behavior and tissue mechanical properties. Calcif Tissue Int. 2010; 87 (5): 450-60.
35. Burstein AH, Wright TW., Mechanical behavior of skeletal structures. In:, Passano WMI, editor. Fundamentals of orthopaedic biomechanics. Baltimore: Williams & Wilkins; p. 133-70. 1994.
36. Atkinson C, Compston JE, Day NE, Dowsett M, Bingham SA., The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2004; 79 (2): 326-33.
37. Ernst M, Schmid C, Froesch ER., Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci USA. 1988; 85 (7): 2307-10.
38. Ganesan K, Tiwari M, Balachandran C, Manohar BM, Puvanakrishnan R., Estrogen and testosterone attenuate extracellular matrix loss in collagen-induced arthritis in rats. Calcif Tissue Int. 2008; 83 (5): 354-64.
39. Ireland DC, Bord S, Beavan SR, Compston JE., Effects of estrogen on collagen synthesis by cultured human osteoblasts depend on the rate of cellular differentiation. J Cell Biochem. 2002; 86 (2): 251-7.
40. Durchschlag E, Paschalis EP, Zoehrer R, et al. Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate. J Bone Miner Res. 2006; 21 (10): 1581-90.
41. Gourion-Arsiquaud S, Allen MR, Burr DB, Vashishth D, Tang SY, Boskey AL., Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone. 2010; 46 (3): 666-72.
42. Paschalis EP, Boskey AL, Kassem M, Eriksen EF., Effect of hormone replacement therapy on bone quality in early postmenopausal women. J Bone Miner Res. 2003; 18 (6): 955-9.
43. Boskey AL, Spevak L, Doty SB, Rosenberg L., Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel. Calcif Tissue Int. 1997; 61 (4): 298-305.
44. Mochida Y, Duarte WR, Tanzawa H, Paschalis EP, Yamauchi M., Decorin modulates matrix mineralization in vitro. Biochem Biophys Res Commun. 2003; 305 (1): 6-9.
45. Mochida Y, Parisuthiman D, Pornprasertsuk-Damrongsri S, et al. Decorin modulates collagen matrix assembly and mineralization. Matrix Biol. 2009; 28 (1): 44-52.
46. Nielsen KL, Allen MR, Bloomfield SA, et al. Biglycan deficiency interferes with ovariectomy-induced bone loss. J Bone Miner Res. 2003; 18 (12): 2152-8.
47. Bi Y, Nielsen KL, Kilts TM, et al. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. Bone. 2006; 38 (6): 778-86.
48. Xu T, Bianco P, Fisher LW, et al. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet. 1998; 20 (1): 78-82.
49. Sauren YM, Mieremet RH, Groot CG, Scherft JP., An electron microscopic study on the presence of proteoglycans in the mineralized matrix of rat and human compact lamellar bone. Anat Rec. 1992; 232 (1): 36-44.
50. Thompson WR, Modla S, Grindel BJ, et al. Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone. J Bone Miner Res. 2011; 26 (3): 618-29.
51. Gualeni B, de Vernejoul MC, Marty-Morieux C, et al. Alteration of proteoglycan sulfation affects bone growth and remodeling. Bone. 2013; 54 (1): 83-91.
52. Ohtsuki T, Hatake K, Suzu S, Saito K, Motoyoshi K, Miura Y., Immunohistochemical identification of proteoglycan form of macrophage colony-stimulating factor on bone surface. Calcif Tissue Int. 1995; 57 (3): 213-7.
53. Smith AJ, Singhrao SK, Newman GR, Waddington RJ, Embery G., A biochemical and immuno-electron microscopical analysis of chondroitin sulphate-rich proteoglycans in human alveolar bone. Histochem J. 1997; 29 (1): 1-9.
54. Boskey AL, Reddi AH., Changes in lipids during matrix: induced endochondral bone formation. Calcif Tissue Int. 1983; 35 (4-5): 549-54.
55. Goldberg M, Boskey AL., Lipids and biomineralizations. Prog histochem cytochem. 1996; 31 (2): 1-187.
56. Raggio CL, Boyan BD, Boskey AL., In vivo hydroxyapatite formation induced by lipids. J Bone Miner Res. 1986; 1 (5): 409-15.
57. Paschalis EP., Fourier transform infrared analysis and bone. Osteoporos Int. 2009; 20 (6): 1043-7.
58. Paschalis EP, Mendelsohn R, Boskey AL., Infrared assessment of bone quality: a review. Clin Orthop Relat Res. 2011; 469 (8): 2170-8.
59. Boskey AL, DiCarlo E, Paschalis E, West P, Mendelsohn R., Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation. Osteoporos Int. 2005; 16 (12): 2031-8.
60. Fratzl P, Roschger P, Eschberger J, Abendroth B, Klaushofer K., Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle x-ray-scattering study. J Bone Miner Res. 1994; 9 (10): 1541-9.
61. Gupta HS, Seto J, Wagermaier W, Zaslansky P, Boesecke P, Fratzl P., Cooperative deformation of mineral and collagen in bone at the nanoscale. Proc Natl Acad Sci USA. 2006; 103 (47): 17741-6.
62. Jager I, Fratzl P., Mineralized collagen fibrils: a mechanical model with a staggered arrangement of mineral particles. Biophys J. 2000; 79 (4): 1737-46.
63. Paschalis EP, Betts F, DiCarlo E, Mendelsohn R, Boskey AL., FTIR microspectroscopic analysis of human iliac crest biopsies from untreated osteoporotic bone. Calcif Tissue Int. 1997; 61 (6): 487-92.
64. Yamauchi M., Collagen: The major matrix molecule in mineralized tissues In:, Anderson JJB, Garner SC, (eds.) Calcium and Phosphorus in Health and Disease, New York: CRC Press; p. 127-41. 1996.
65. Masse PG, Rimnac CM, Yamauchi M, et al. Pyridoxine deficiency affects biomechanical properties of chick tibial bone. Bone. 1996; 18 (6): 567-74.
66. Oxlund H, Barckman M, Ortoft G, Andreassen TT., Reduced concentrations of collagen cross-links are associated with reduced strength of bone. Bone. 1995; 17 (4 Suppl): 365S-71S.
67. Bank RA, Robins SP, Wijmenga C, et al. Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc Natl Acad Sci USA. 1999; 96 (3): 1054-8.
68. Bank RA, Tekoppele JM, Janus GJ, et al. Pyridinium cross-links in bone of patients with osteogenesis imperfecta: evidence of a normal intrafibrillar collagen packing. J Bone Miner Res. 2000; 15 (7): 1330-6.
69. Eyre D, Wu J., Collagen cross-links. Top Curr Chem. 2005; 247: 207-29.
70. Avery NC, Bailey AJ., Enzymic and non-enzymic cross-linking mechanisms in relation to turnover of collagen: relevance to aging and exercise. Scand J Med Sci Sports. 2005; 15 (4): 231-40.
71. Robins S., Biochemistry and functional significance of collagen cross-linking. Biochem Soc Trans. 2007; 35: 849-52.